Genetic Engineering & Biotechnology News

AUG 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/1007345

Contents of this Issue

Navigation

Page 30 of 33

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products GENengnews.com | Genetic Engineering & Biotechnology News | AUGUST 2018 | 29 People 3D Printing and Additive Manufacturing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 Advanced Analytical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,13 BioSpec . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 Carterra . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Cayman Chemical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Clinical OMICs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 CRISPR Journal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Eppendorf . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 GEN/Bio-Techne webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 GEN/DNA Software webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 GEN/Unchained Labs webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Horizon Discovery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 m2p Labs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 OriGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 SelectBio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 Sonntek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 Advertiser Index AXIAL BIOTHERAPEUTICS established a scientific advisory board, consisting of: Patrik Brundin, M.D., Ph.D., Lode Dewulf, MD., D.P.M., Marie-Francoise Chesselet, M.D., Ph.D., Peter Hutt II, Marty Jefson, Ph.D., Torsten Madsen, M.D., Ph.D., Steven M. Opal, M.D., and Kathleen M. Shannon, M.D. BIOASIS appointed Mario Saltarelli, M.D., Ph.D., Jack Hoppin, Ph.D., and Sue O'Connor, Ph.D., to its scientific advisory board . Hong Yu is the new president of BIOSTAGE . BICYCLE THERAPEUTICS convened a scientific advisory board, consisting of: Vincenzo Cerundolo, JC Gutiérrez-Ramos, Ph.D., Sir Keith Peters, Sc.D., Sergio Quezada, Ph.D., Ed Scolnick, Ph.D., Geoffrey Shapiro, M.D., Ph.D., Nicholas Turner, BM BCh, Ph.D., and Sir Gregory Winter, Ph.D. AZYIO BIOLOGICS welcomed Ronald Lloyd as president and CEO . Ming Liu, Ph.D., joined CHEMPARTNER as vice president and head of biology and pharmacology . ONCOBIOLOGICS appointed Randy Thurman as executive chairman of the board and promoted Lawrence A. Kenyon as interim CEO . VIVET THERAPEUTICS elected Eduardo Bravo as chair of the board . H3 BIOMEDICINE promoted Lihua Yu, Ph.D., to president and CEO . Jeffrey Lawson, M.D., Ph.D., is the new president and CEO of HUMACYTE . AIMMUNE THERAPEUTICS welcomed Jayson Dallas, M.D., as president and CEO . RESEARCHPOINT GLOBAL welcomed José Iglesias, M.D., as medical director, oncology . Yaping Shou, M.D., Ph.D., is the new CMO of TRILLIUM THERAPEUTICS . Harold H. Shlevin, Ph.D., is the new CEO of GALECTIN THERAPEUTICS . RUBIUS THERAPEUTICS hired Pablo J. Cagnoni, M.D., as CEO . He most recently served as president and CEO of Tizona Therpetics . Earlier in his career, Dr . Cagnoni was president of Onyx Pharmaceu- ticals, global head of clinical development at Novartis Oncology, and CMO at Allos Therapeutics and OSI Pharmaceuticals, respectively . Profile Rahul D. Ballal, Ph.D., joined IMARA as CEO . He is the former CBO of Northern Biologics, and was an entrepreneur-in- residence at Versant Ventures . Prior to that, Dr . Ballal was vice president, business develop- ment, at Flexion Therapeutics . Profile AXCELLA HEALTH welcomed William (Bill) Hinshaw as president and CEO . He was most recently executive vice president and head of U . S . oncology at Novartis . Prior to that, he held several roles at Schering Plough, including head of U . S . oncology . Profile Reprints Call 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in printed or electronic form — to increase awareness of your product or company. Order today! Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S ePUB Molecular Diagnostics in Personalized Medicine Subscribe Send your People Announcements to people@GENengnews.com Mini Bead Beater 24 SoniBeast Tissue Tearor Mini Bead Beater 16 Mini Bead Beater 96 CELL DISRUPTER Bio Pulverizer Cryo Cup Bio Vortexer 800.617.3363 TISSUE DISPERSER Micro Mincer Classified

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - AUG 2018